UV Germi SA (EPA:ALUVI)

UV Germi Statistics

Total Valuation

UV Germi has a market cap or net worth of EUR 7.98 million. The enterprise value is 3.39 million.

Market Cap	7.98M
Enterprise Value	3.39M

Important Dates

The next estimated earnings date is Thursday, July 30, 2026.

Earnings Date	Jul 30, 2026
Ex-Dividend Date	n/a

Share Statistics

UV Germi has 3.21 million shares outstanding. The number of shares has increased by 0.83% in one year.

Current Share Class	3.21M
Shares Outstanding	3.21M
Shares Change (YoY)	+0.83%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.97%
Owned by Institutions (%)	n/a
Float	1.41M

Valuation Ratios

The trailing PE ratio is 78.81.

PE Ratio	78.81
Forward PE	n/a
PS Ratio	1.13
PB Ratio	0.80
P/TBV Ratio	0.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	33.43
EV / Sales	0.48
EV / EBITDA	7.33
EV / EBIT	59.12
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.80, with a Debt / Equity ratio of 0.02.

Current Ratio	7.80
Quick Ratio	5.48
Debt / Equity	0.02
Debt / EBITDA	0.51
Debt / FCF	n/a
Interest Coverage	7.31

Financial Efficiency

Return on equity (ROE) is 1.02% and return on invested capital (ROIC) is 0.36%.

Return on Equity (ROE)	1.02%
Return on Assets (ROA)	0.32%
Return on Invested Capital (ROIC)	0.36%
Return on Capital Employed (ROCE)	0.56%
Weighted Average Cost of Capital (WACC)	5.70%
Revenue Per Employee	180,721
Profits Per Employee	2,598
Employee Count	39
Asset Turnover	0.63
Inventory Turnover	1.50

Taxes

Income Tax	-80,282
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.96% in the last 52 weeks. The beta is 0.28, so UV Germi's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+5.96%
50-Day Moving Average	2.40
200-Day Moving Average	2.64
Relative Strength Index (RSI)	49.18
Average Volume (20 Days)	2,614

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, UV Germi had revenue of EUR 7.05 million and earned 101,308 in profits. Earnings per share was 0.03.

Revenue	7.05M
Gross Profit	3.11M
Operating Income	57,287
Pretax Income	21,026
Net Income	101,308
EBITDA	462,220
EBIT	57,287
Earnings Per Share (EPS)	0.03

Balance Sheet

The company has 4.83 million in cash and 236,000 in debt, with a net cash position of 4.60 million or 1.43 per share.

Cash & Cash Equivalents	4.83M
Total Debt	236,000
Net Cash	4.60M
Net Cash Per Share	1.43
Equity (Book Value)	9.94M
Book Value Per Share	3.10
Working Capital	8.10M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	404,933
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 44.11%, with operating and profit margins of 0.81% and 1.44%.

Gross Margin	44.11%
Operating Margin	0.81%
Pretax Margin	0.30%
Profit Margin	1.44%
EBITDA Margin	6.56%
EBIT Margin	0.81%
FCF Margin	n/a

Dividends & Yields

UV Germi does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.83%
Shareholder Yield	-0.83%
Earnings Yield	1.27%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

UV Germi has an Altman Z-Score of 5.13 and a Piotroski F-Score of 3.

Altman Z-Score	5.13
Piotroski F-Score	3